Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2

Laboratories faced many challenges throughout the COVID-19 pandemic. Point-of-care (POC) SARS-CoV-2 nucleic acid amplification tests (NAATs) provided a key solution to the need for rapid turnaround time in select patient populations and were implemented at the POC but also within laboratories to sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolan, Nicole V., Horowitz, Gary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894858/
https://www.ncbi.nlm.nih.gov/pubmed/35636823
http://dx.doi.org/10.1016/j.cll.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894858/
https://www.ncbi.nlm.nih.gov/pubmed/35636823
http://dx.doi.org/10.1016/j.cll.2022.03.002

Ejemplares similares